These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36317783)

  • 1. Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.
    Kayentao K; Ongoiba A; Preston AC; Healy SA; Doumbo S; Doumtabe D; Traore A; Traore H; Djiguiba A; Li S; Peterson ME; Telscher S; Idris AH; Kisalu NK; Carlton K; Serebryannyy L; Narpala S; McDermott AB; Gaudinski M; Traore S; Cisse H; Keita M; Skinner J; Hu Z; Zéguimé A; Ouattara A; Doucoure M; Dolo A; Djimdé A; Traore B; Seder RA; Crompton PD;
    N Engl J Med; 2022 Nov; 387(20):1833-1842. PubMed ID: 36317783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monoclonal Antibody for Malaria Prevention.
    Gaudinski MR; Berkowitz NM; Idris AH; Coates EE; Holman LA; Mendoza F; Gordon IJ; Plummer SH; Trofymenko O; Hu Z; Campos Chagas A; O'Connell S; Basappa M; Douek N; Narpala SR; Barry CR; Widge AT; Hicks R; Awan SF; Wu RL; Hickman S; Wycuff D; Stein JA; Case C; Evans BP; Carlton K; Gall JG; Vazquez S; Flach B; Chen GL; Francica JR; Flynn BJ; Kisalu NK; Capparelli EV; McDermott A; Mascola JR; Ledgerwood JE; Seder RA;
    N Engl J Med; 2021 Aug; 385(9):803-814. PubMed ID: 34379916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
    Kayentao K; Ongoiba A; Preston AC; Healy SA; Hu Z; Skinner J; Doumbo S; Wang J; Cisse H; Doumtabe D; Traore A; Traore H; Djiguiba A; Li S; Peterson ME; Telscher S; Idris AH; Adams WC; McDermott AB; Narpala S; Lin BC; Serebryannyy L; Hickman SP; McDougal AJ; Vazquez S; Reiber M; Stein JA; Gall JG; Carlton K; Schwabl P; Traore S; Keita M; Zéguimé A; Ouattara A; Doucoure M; Dolo A; Murphy SC; Neafsey DE; Portugal S; Djimdé A; Traore B; Seder RA; Crompton PD;
    N Engl J Med; 2024 May; 390(17):1549-1559. PubMed ID: 38669354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
    Lyke KE; Berry AA; Mason K; Idris AH; O'Callahan M; Happe M; Strom L; Berkowitz NM; Guech M; Hu Z; Castro M; Basappa M; Wang L; Low K; Holman LA; Mendoza F; Gordon IJ; Plummer SH; Trofymenko O; Strauss KS; Joshi S; Shrestha B; Adams M; Chagas AC; Murphy JR; Stein J; Hickman S; McDougal A; Lin B; Narpala SR; Vazquez S; Serebryannyy L; McDermott A; Gaudinski MR; Capparelli EV; Coates EE; Wu RL; Ledgerwood JE; Dropulic LK; Seder RA;
    Lancet Infect Dis; 2023 May; 23(5):578-588. PubMed ID: 36708738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
    Wu RL; Idris AH; Berkowitz NM; Happe M; Gaudinski MR; Buettner C; Strom L; Awan SF; Holman LA; Mendoza F; Gordon IJ; Hu Z; Campos Chagas A; Wang LT; Da Silva Pereira L; Francica JR; Kisalu NK; Flynn BJ; Shi W; Kong WP; O'Connell S; Plummer SH; Beck A; McDermott A; Narpala SR; Serebryannyy L; Castro M; Silva R; Imam M; Pittman I; Hickman SP; McDougal AJ; Lukoskie AE; Murphy JR; Gall JG; Carlton K; Morgan P; Seo E; Stein JA; Vazquez S; Telscher S; Capparelli EV; Coates EE; Mascola JR; Ledgerwood JE; Dropulic LK; Seder RA;
    N Engl J Med; 2022 Aug; 387(5):397-407. PubMed ID: 35921449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016.
    Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA
    Malar J; 2021 May; 20(1):235. PubMed ID: 34034754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
    Sagara I; Healy SA; Assadou MH; Gabriel EE; Kone M; Sissoko K; Tembine I; Guindo MA; Doucoure M; Niaré K; Dolo A; Rausch KM; Narum DL; Jones DL; MacDonald NJ; Zhu D; Mohan R; Muratova O; Baber I; Coulibaly MB; Fay MP; Anderson C; Wu Y; Traore SF; Doumbo OK; Duffy PE
    Lancet Infect Dis; 2018 Sep; 18(9):969-982. PubMed ID: 30061051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India.
    Krishna S; Mishra S; Tiwari P; Vishwakarma AK; Khandai S; Shrivastava S; Verma AK; Tiwari S; Barman H; Jhariya S; Tiwari P; Tidgam AS; Varun BM; Singh S; Yerane N; Tembhurne CR; Mandavi PL; Tekam SS; Malik M; Behera KP; Jayswar H; Sonwani K; Diggikar MS; Pradhan MM; Khasotiya SS; Kumar A; Dhingra N; Bustos MDG; Christophel EM; Ringwald P; Kumari R; Shukla MM; Singh N; Das A; Bharti PK
    Malar J; 2021 May; 20(1):229. PubMed ID: 34020652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
    Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
    BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II Pilot Trial to Evaluate
    Noudjiegbe AN; Alikekere FN; Tchehouenou H; Langa Y; Ota DS; Degbelo JE; Allabi ACE
    Evid Based Complement Alternat Med; 2020; 2020():8715021. PubMed ID: 32215047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.